Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Atlantic American Corp
AAME
$30.2M
| $82K | ﹤0.01% |
33,400
+300
| +0.9% | +$565 |
|
|
ZSTK
3352
ZeroStack Corp
ZSTK
$21.1M
| $82K | ﹤0.01% |
1,554
+531
| +52% | +$20.9K |
|
3353
PharmaCyte Biotech
PMCB
$5.88M
| $82K | ﹤0.01% |
38,100
+5,200
| +16% | +$11.3K |
|
|
WHLM
3354
DELISTED
Wilhelmina International, Inc
WHLM
| $82K | ﹤0.01% |
20,000
| – | – |
|
|
LUNA
3355
DELISTED
Luna Innovations Incorporated
LUNA
| $82K | ﹤0.01% |
12,377
-15,924
| -56% | -$98.3K |
|
3356
Modular Medical
MODD
$11.2M
| $81K | ﹤0.01% |
1,483
+1,000
| +207% | +$38.4K |
|
|
VIOT
3357
Viomi Technology
VIOT
$48M
| $81K | ﹤0.01% |
80,764
+700
| +0.9% | +$645 |
|
|
TFFP
3358
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $81K | ﹤0.01% |
11,497
+5,277
| +85% | +$41K |
|
3359
Matinas BioPharma
MTNB
$1.49M
| $80K | ﹤0.01% |
7,433
+3,146
| +73% | +$35.5K |
|
3360
NanoViricides
NNVC
$34.9M
| $80K | ﹤0.01% |
78,500
+2,400
| +3% | +$2.77K |
|
|
DXYN
3361
DELISTED
Dixie Group Inc
DXYN
| $80K | ﹤0.01% |
107,533
+8,533
| +9% | +$5.79K |
|
3362
Milestone Scientific
MLSS
$48.9M
| $79K | ﹤0.01% |
114,397
+86,500
| +310% | +$68.9K |
|
3363
TRX Gold Corp
TRX
$341M
| $79K | ﹤0.01% |
207,259
-232,055
| -53% | -$91.5K |
|
|
DYNT
3364
DELISTED
Dynatronics Corp
DYNT
| $79K | ﹤0.01% |
135,418
+700
| +0.5% | +$403 |
|
|
AACG
3365
ATA Creativity
AACG
$48M
| $78K | ﹤0.01% |
67,444
-6,600
| -9% | -$6.33K |
|
3366
Fortress Biotech
FBIO
$91.4M
| $78K | ﹤0.01% |
25,867
+4,292
| +20% | +$11.3K |
|
3367
HeartCore Enterprises
HTCR
$3.88M
| $78K | ﹤0.01% |
6,075
+115
| +2% | +$1.58K |
|
3368
Owlet
OWLT
$169M
| $77K | ﹤0.01% |
14,598
-1,600
| -10% | -$7.85K |
|
|
EIGR
3369
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $77K | ﹤0.01% |
+11,474
| New | +$101K |
|
|
CMCM
3370
Cheetah Mobile
CMCM
$93.7M
| $76K | ﹤0.01% |
33,545
-600
| -2% | -$1.17K |
|
|
MSC
3371
Studio City International Holdings
MSC
$333M
| $76K | ﹤0.01% |
11,800
-2,200
| -16% | -$11.7K |
|
|
SONN
3372
DELISTED
Sonnet BioTherapeutics
SONN
| $76K | ﹤0.01% |
5,469
+3,088
| +130% | +$42K |
|
|
HLTH
3373
DELISTED
Cue Health Inc. Common Stock
HLTH
| $76K | ﹤0.01% |
466,600
+142,800
| +44% | +$47.4K |
|
|
OGG
3374
Osisko Gold Group Inc.
OGG
$835M
| $75K | ﹤0.01% |
+25,698
| New | +$77.5K |
|
|
MMAT
3375
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $75K | ﹤0.01% |
+11,405
| New | +$136K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.